Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Growth”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04158505
What this trial is testing

Real World Study of Pyrotinib in Human Epidermal Growth Factor Receptor-2 (HER2) Positive Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
Chinese Academy of Medical Sciences 3,000
Testing effectiveness (Phase 2)Study completedNCT00410696
What this trial is testing

Pegfilgrastim Versus Filgrastim After High-dose Chemotherapy

Who this might be right for
Hematological NeoplasmsTumors
Armando Santoro, MD 80
Early research (Phase 1)Active Not RecruitingNCT05364073
What this trial is testing

Study of Furmonertinib in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Activating, Including Uncommon, Epidermal Growth Factor Receptor (EGFR) or Human Epidermal Growth Factor Receptor 2 (HER2) Mutations

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)Metastatic Non-Small Cell Lung CancerAdvanced Non-Small Cell Lung Cancer+3 more
ArriVent BioPharma, Inc. 160
Early research (Phase 1)UnknownNCT02691871
What this trial is testing

Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Lung Adenocarcinoma Harboring Wild-type EGFR

Who this might be right for
Lung Adenocarcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 20
Post-approval studies (Phase 4)Study completedNCT01609543
What this trial is testing

Tarceva (Erlotinib) in First Line in Patients With Locally Advanced or Metastatic Lung Adenocarcinoma With EGFR Mutations

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Hoffmann-La Roche 62
Early research (Phase 1)Study completedNCT00903734
What this trial is testing

An Umbrella, Modular Study Based on Epidermal Growth Factor Receptor (EGFR) Mutation Status

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT05607004
What this trial is testing

(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer

Who this might be right for
Breast NeoplasmsInvasive Breast CancerEstrogen-receptor-positive Breast Cancer+1 more
Atossa Therapeutics, Inc. 87
Not applicableStudy completedNCT05912933
What this trial is testing

Learn About the Relationship Between Hepatic Impairment and Myelosuppression (Decreased Bone Marrow Function) in Breast Cancer Patients Treated With the Study Medicine Palbociclib (Pal-bow-sai-klib)

Who this might be right for
Breast Cancer
Pfizer 1,342
Testing effectiveness (Phase 2)Study completedNCT01719549
What this trial is testing

Dovitinib for Gastric Cancer With FGFR2 Amplification: GASDOVI-1

Who this might be right for
Gastric Cancer
Asan Medical Center 19
Testing effectiveness (Phase 2)Study completedNCT00940316
What this trial is testing

Dual Epidermal Growth Factor Receptor Inhibition With Erlotinib and Panitumumab With or Without Chemotherapy for Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Northwestern University 28
Large-scale testing (Phase 3)Ended earlyNCT02186301
What this trial is testing

TIGER-1: Safety and Efficacy Study of Rociletinib (CO-1686) or Erlotinib in Patients With EGFR-mutant/Metastatic NSCLC Who Have Not Had Any Previous EGFR Directed Therapy

Who this might be right for
Non-Small Cell Lung Cancer
Clovis Oncology, Inc. 100
Testing effectiveness (Phase 2)UnknownNCT02285530
What this trial is testing

GDF15 Based TPF Induction Chemotherapy for OSCC Patients

Who this might be right for
Mouth NeoplasmsCarcinoma, Squamous Cell
Shanghai Jiao Tong University School of Medicine 72
Testing effectiveness (Phase 2)WithdrawnNCT02846766
What this trial is testing

Study of Lenvatinib in Patients With Advanced Cancer and Aberrations in FGF/FGFR Signaling

Who this might be right for
Cancer
Teresa Helsten, MD
Not applicableStudy completedNCT02750956
What this trial is testing

Endocan, VEGF and TNF-alpha Levels in Periodontal Disease and After Treatment

Who this might be right for
Periodontal Disease
Bulent Ecevit University 40
Large-scale testing (Phase 3)Study completedNCT01358877
What this trial is testing

Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 4,804
Early research (Phase 1)Study completedNCT01046266
What this trial is testing

Pharmacodynamics of RO5083945 in Patients With Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Cancer
Hoffmann-La Roche 62
Not applicableStudy completedNCT02913456
What this trial is testing

A European Registry Study to Prospectively Observe Treatment Patterns and Outcomes in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Unresectable Locally Advanced (LA) or Metastatic Breast Cancer (mBC) (SAMANTHA)

Who this might be right for
Breast Cancer
Hoffmann-La Roche 629
Early research (Phase 1)Study completedNCT00283075
What this trial is testing

Mouse Cancer Cell-containing Macrobeads in the Treatment of Human Cancer

Who this might be right for
Intraabdominal Cancers (Various Types)
The Rogosin Institute 56
Testing effectiveness (Phase 2)Ended earlyNCT00807612
What this trial is testing

QUILT-2.017: Phase 1b/2 Study of AMG 479 in Combination With Paclitaxel and Carboplatin for 1st Line Treatment of Advanced Squamous Non-Small Cell Lung Cancer

Who this might be right for
Advanced Squamous Non-Small Cell Lung Cancer
NantCell, Inc. 15
Not applicableStudy completedNCT04076787
What this trial is testing

Clinical Outcomes for Patients With Renal Cell Carcinoma Who Received First-Line Sunitinib

Who this might be right for
Metastatic Renal Cell Carcinoma
Pfizer 1,769
Next Page